CONMED Corporation (CNMD.O)

CNMD.O on Nasdaq

22.37USD
9 Feb 2010
Price Change (% chg)

$0.20 (+0.90%)
Prev Close
$22.37
Open
--
Day's High
$22.85
Day's Low
$22.27
Volume
211,254
Avg. Vol
192,706
52-wk High
$24.43
52-wk Low
$11.56

CNMD.O

Chart for CNMD.O

About

CONMED Corporation (CONMED) is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures and monitoring. The Company’s products serve the clinical areas of arthroscopy, powered surgical instruments, electrosurgery, patient care, endosurgery and endoscopic technologies.... (more)

Overall

Beta: 0.91
Market Cap (Mil.): $651.05
Shares Outstanding (Mil.): 29.10
Annual Dividend: 0.00
Yield (%): NA

Financials

  CNMD.O Industry Sector
P/E (TTM): 53.78 4.05 3.76
EPS (TTM): -69.65 -- --
ROI: 1.40 2.37 2.30
ROE: 2.17 3.77 2.82
view overview for:

Latest News about CNMD.O

UPDATE 1-Conmed Q3 beats market view, sees strong Q4; shares up

* Forecasts Q4, FY 2010 rev above estimates * Sees Q4 adj EPS $0.30-$0.35, sales $178-$183 mln

22 Oct 2009

UPDATE 1-Conmed posts lower Q1 profit, cuts '09 view

April 23 (Reuters) - Medical device maker Conmed Corp posted a 52 percent drop in quarterly profit, forecast second-quarter earnings below market estimates and cut its 2009 outlook.

23 Apr 2009

UPDATE 1-Conmed Q4 results top market estimates

Feb 5 (Reuters) - Medical-device maker Conmed Corp posted a better-than-expected fourth-quarter profit, a month after it had cut its outlook for the same period, helped in part by higher sales of its single-use products, and forecast first-quarter revenue below analysts' estimates.

05 Feb 2009

UPDATE 2-Conmed cuts Q4, 2009 view, shares tank

BANGALORE, Jan 5 (Reuters) - Medical technology company Conmed Corp cut its fourth-quarter and 2009 outlook, hurt by strengthening of the U.S. dollar and lower sales of its capital equipment, sending its shares down 31 percent to their lowest in more than five years.

05 Jan 2009

UPDATE 1-Conmed Q3 profit tops Wall St view, ups FY outlook

Oct 23 (Reuters) - Conmed Corp posted higher-than-expected quarterly earnings and raised its full-year profit forecast, sending its shares up as much as 9 percent. [ID:nWNAB0455]

23 Oct 2008

TEXT-S&P release on ConMed Corp

(The following statement was released by the ratings agency)

09 Jan 2008

ConMed says president of orthopedic unit resigns

Jan 4 (Reuters) - Medical technology company ConMed Corp said Gerald Woodard, the president of its unit ConMed Linvatec has resigned, effective Jan. 30, to become chief executive of SRI/Surgical Express Inc .

04 Jan 2008

SRI/Surgical names CEO

Jan 4 (Reuters) - SRI/Surgical Express Inc named Gerald Woodard chief executive officer, effective Jan. 31.

04 Jan 2008

Conmed Q3 results

CONMED CORP : * Third quarter GAAP earnings per share $0.29 * Forecasts fiscal year 2007 non-GAAP earnings per share $1.30 to $1.34 * Forecasts fourth quarter earnings per share $0.36 to $0.40 * Third quarter sales rose 6.1 percent to $164.4 million * Forecasts fiscal year 2008 earnings per share $1.47 to $1.52 * Reuters Estimates third quarter earnings per share view $0.29, revenue view $165.4 million * Reuters Estimates fourth quarter earnings per share view $0.37 * Reuters Estim

25 Oct 2007

UPDATE 1-TABLE-Conmed Q2 earnings up, raises 2007 view

CONMED CORP. (in $) Latest Yr ago qtr EPS (diluted) 0.32 0.12 EPS, before items 0.35 0.23 Net (million) 9.3 3.4 Net sales (million) 169.3 163.5 Reuters Estimates: EPS $0.28 (two analysts), revenue $164.1 million (two analysts).

26 Jul 2007
» More CNMD.O News

Competitors

  Price Change
Smith & Nephew plc (SN.L) £635.00 -0.50
Stryker Corporation (SYK.N) $51.91 +0.48
ArthroCare Corporation (ARTC.OQ) $25.81 -0.23
Johnson & Johnson (JNJ.N) $62.76 +0.39
Medtronic, Inc. (MDT.N) $42.36 +0.57
Covidien Ltd. (COV.N) $49.55 +0.09
3M Company (MMM.N) $78.72 +1.19
Boston Scientific Corporation (BSX.N) $8.23 +0.08

  Earnings  vs    Estimates

view overview for: